Ryogen's patent portfolio consists of 36 issued U.S. patents and a number of patent applications which are directed to genes that play important roles in various cancers, diabetes and obesity, hepatitis C, atherosclerosis, Alzheimer's and other diseases. It covers large segments of human chromosomes X, 1, 6, 7, 10, 11, 12, 17 and 19.
U.S. Patent No. 8,956,819
U.S. Patent No. 8,956,819 entitled “Identification of human mouse double minute 2 homolog nucleotide sequences ” was issued on February 17, 2015.
U.S. Patent No. 8,822,145
U.S. Patent No. 8,822,145 entitled “Identification of POLD2 sequences” was issued on September 2, 2014.
U.S. Patent No. 8,795,959
U.S. Patent No. 8,795,959 entitled “Isolated glucokinase genomic polynucleotide fragments from chromosome 7” was issued on August 5, 2014.
U.S. Patent No. 8,771,956
U.S. Patent No. 8,771,956 entitled “Modulation of human mouse double minute 2 homolog activity” was issued on July 8, 2014.
U.S. Patent No. 8,765,928
U.S. Patent No. 8,765,928 entitled “Identification of isolated genomic nucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 4 (TSSC4) and variants thereof" was issued on July 1, 2014.
U.S. Patent No. 8,765,927
U.S. Patent No. 8,765,927 entitled “Identification of isolated genomic nucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 4 (TSSC4) and variants thereof" was issued on July 1, 2014.
U.S. Patent No. 8,722,865
U.S. Patent No. 8,722,865 entitled “Identification of isolated genomic nucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 4 (TSSC4) and variants thereof” was issued on July 1, 2014.
U.S. Patent No. 8,399,642
U.S. Patent No. 8,399,642 entitled "Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26)" issued on March 19, 2013.
U.S. Patent No. 8,399,641
U.S. Patent No. 8,399,641 entitled "Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 6 (TSSC6)" was granted on March 19, 2013.
U.S. Patent No. 8,399,640
U.S. Patent No. 8,399,640 entitled "Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human SMS3" issued on March 19, 2013.
U.S. Patent No. 8,399,639
U.S. Patent No. 8,399,639 entitled "Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human achaete-scute homolog 2 (HASH2)" was granted on March 19, 2013.
U.S. Patent No. 8,399,638
U.S. Patent No. 8,399,638 entitled "Isolated genomic polynucleotide fragments from the p15 region of chromosome 11" issued on March 19, 2013.
U.S. Patent No. 8,372,588
U.S. Patent No. 8,372,588 entitled "Isolated 3'-noncoding Genomic Human Resistin Polynucleotide Fragments" was granted on February 12, 2013.
U.S. Patent No. 8,338,100
U.S. Patent No. 8,338,100 entitled "Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidase M" was issued on December 25, 2012.
U.S. Patent No. 8,323,884
U.S. Patent No. 8,323,884 entitled "Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses" was granted on December 4, 2012.
U.S. Patent No. 8,313,910
U.S. Patent No. 8,313,910 entitled "Isolated genomic polynucleotide fragments from chromosome 12 that encode human mouse double minute 2 homolog" was issued on November 20, 2012.
U.S. Patent No. 8,313,900
U.S. Patent No. 8,313,900 entitled "Isolated DNA directed 50kD regulatory subunit (POLD2) genomic polynucleotide fragments from chromosome 7 and their uses" was issued on November 20, 2012.
U.S. Patent No. 8,313,899
U.S. Patent No. 8,313,899 called "Isolated snare YKT6 genomic polynucleotide fragments from chromosome 7 and their uses" was issued on November 20, 2012.
U.S. Patent No. 8,283,118
U.S. Patent No. 8,283,118 entitled "Isolated genomic polynucleotide fragments from chromosome 19 that encode human syntaxin binding protein 2" was granted on October 9, 2012.
U.S. Patent No. 8,258,273
U.S. Patent No. 8,258,273 entitled "Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P" was issued on September 4, 2012.
U.S. Patent No. 8,241,849
U.S. Patent No. 8,241,849 entitled "Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2" was granted on August 14, 2012.
U.S. Patent No. 8,178,662
U.S. Patent No. 8,178,662 titled "Isolated AEBP1 genomic polynucleotide fragments from chromosome 7 and their uses" was issued on May 15, 2012.
U.S. Patent No. 8,058,052
U.S. Patent No. 8,058,052 "Isolated genomic polynucleotide fragments from chromosome 12 that encode human Carboxypeptidse M" was granted on November 15, 2011.
U.S. Patent No. 8,057,998
U.S. Patent No. 8,057,998 titled "Isolated genomic polynucleotide fragments from chromosome 19 that encode human syntaxin" was issued November 15, 2011.
U.S. Patent No. 8,053,195
U.S. Patent No. 8,053,195 titled "Isolated genomic nucleic acid molecules obtainable from chromosome 1p21-p13 that encode human RhoC" was issued on November 8, 2011.
U.S. Patent No. 8,039,602
U.S. Patent No. 8,039,602 "Isolated genomic polynucleotide fragments from the p15 region of chromosome 11" was granted on October 18, 2011.
U.S. Patent No. 8,012,687
U.S. Patent No. 8,012,687 "Isolated genomic polynucleotide fragments from chromosome 19 that encode human resistin and the human syntaxin binding protein 2" was issued September 6, 2011.
U.S. Patent No. 7,985,571
U.S. Patent No. 7,985,571 named "Isolated genomic polynucleotide fragments from chromosome 17 that encode human carboxypeptidase D" was issued by the U.S. Patent and Trademark Office on July 26, 2011.
U.S. Patent No. 7,964,357
U.S. Patent No. 7,964,357 "Isolated genomic polynucleotide fragments from chromosome 12 that encode human mouse double minute 2 homolog" was issued by the U.S. Patent and Trademark Office on June 21, 2011.
U.S. Patent No. 7,786,280
U.S. Patent No. 7,786,280 "Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P " was issued by the U.S. Patent and Trademark Office on August 31, 2010.
U.S. Patent No. 7,754,424
U.S. Patent No. 7,754,424 "Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidase M and the human mouse double minute 2 homolog" was issued by the U.S. Patent and Trademark Office on July 13, 2010.
U.S. Patent No. 7,588,915
U.S. Patent No. 7,588,915 titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7" was granted on September 15, 2009.
U.S. Patent No. 7,470,522
U.S. Patent No. 7,470,522 titled "Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2" was granted on December 30, 2008.
U.S. Patent No. 7,468,266
U.S. Patent No. 7,468,266 entitled "Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2" was awarded on December 23, 2008.
U.S. Patent No. 7,273,718
U.S. Patent No. 7,273,718 entitled "Isolated Genomic Polynucleotide Fragments from Chromosome 10q25.3 that Encode Human Soluble Aminopeptidase P", was issued on September 25, 2007.
U.S. Patent No. 6,399,349
U.S. Patent No. 6,399,349 entitled "Human Aminopeptidase P Gene" was issued on June 4, 2002.